CoChat

BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma

Galmiche, Antoine, Ezzoukhry, Zakaria, François, Catherine, Louandre, Christophe, Sabbagh, Charles, Nguyen-Khac, Eric, Descamps, Véronique, Trouillet, Nathalie, Godin, Corinne, Regimbeau, Jean-Marc, Joly, Jean-Paul, Barbare, Jean-Claude, Duverlie, Gilles, Mazière, Jean-Claude, Chatelain, Denis · 2010 · Molecular Cancer Research
Cited by 50

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Proteins of the BCL2 family are key regulators of apoptosis. Their expression levels are frequently altered in cancers, enabling tumor cells to survive. To gain insight into the pathogenesis of hepatocellular carcinoma (HCC), we performed a comprehensive survey of the expression of the members of the BCL2 family in samples obtained from surgically resected HCCs. Here, we report the occurrence of a new molecular anomaly, consisting of a strong reduction in the expression of the proapoptotic protein BAD in HCC compared with surrounding nontumoral tissue. We investigate the function of BAD in a panel of HCC cell lines. Using gene overexpression and RNA interference, we show that BAD is involved in the cytotoxic effects of sorafenib, a multikinase blocker, which is currently the sole therapeutic drug effective for the treatment of HCC. Finally, we report that ABT-737, a compound that interacts with proteins of the BCL2 family and exhibits a BAD-like reactivity, sensitizes HCC cells toward sorafenib-induced apoptosis. Collectively, our findings indicate that BAD is a key regulator of apoptosis in HCC and an important determinant of HCC cell response to sorafenib. Mol Cancer Res; 8(8); 1116–25. ©2010 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1541-7786.mcr-10-0029

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 50

Metadata

Authors
Galmiche, A., Ezzoukhry, Z., François, C., Louandre, C., Sabbagh, C., Nguyen-Khac, E., Descamps, V., Trouillet, N., Godin, C., Regimbeau, J.-M., Joly, J.-P., Barbare, J.-C., Duverlie, G., Mazière, J.-C., & Chatelain, D.
Venue
Molecular Cancer Research
Published
2010-08-16
Volume
8
Issue
8
Pages
1116-1125
ISSN
  • 1541-7786 (ISSN-L)
  • 1557-3125
OpenAlex
W2099922048
Cited by
50
References
2
FWCI
1.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma. https://app.cochat.ai/papers/10.1158/1541-7786.mcr-10-0029
The paper
Galmiche, A., Ezzoukhry, Z., François, C., Louandre, C., Sabbagh, C., Nguyen-Khac, E., Descamps, V., Trouillet, N., Godin, C., Regimbeau, J.-M., Joly, J.-P., Barbare, J.-C., Duverlie, G., Mazière, J.-C., & Chatelain, D. (2010). BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.mcr-10-0029

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.